June 12, 2019

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:

(i) the cultivation of the cannabis spp. for medical and scientific purposes; and

(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.

For further information, click below to access our full newsletter.

Last related news

November 21, 2023

The enactment of Law No. 14,597/2023 (known as General Sports Law – GSL) in June of this year marks a milestone for … The protection of IP rights in the new Brazilian sports law

November 7, 2023

On October 27, the Brazilian Finance Ministry (MF) issued a significant regulatory milestone for sports betting activities (Ordinance No. 1,300/2023) which establishes the … Brazilian Finance Ministry Issues New Regulation For Sports Betting Market

October 30, 2023

On October 19, 2023, the Federal Official Gazette (DOU) published Administrative Order 1,184/2023, which provides for the National Health Surveillance Agency’s (Anvisa) … ANVISA’s Personal Data Protection Policy is released